Brief: Spago Nanomedical Q1 Loss For Quarter Widens To SEK 9.9 Mln
April 27 (Reuters) - Spago Nanomedical AB (publ) SPAGO.ST :
* Q1 NET SALES FOR QUARTER AMOUNTED TO KSEK 211 (KSEK 100)
* Q1 LOSS FOR QUARTER AMOUNTED TO KSEK -9,880 (KSEK -6,068)
Source text for Eikon: ID:nMFN6s94CK
Further company coverage: SPAGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose